Day One Biopharmaceuticals
DAWN
C$9.62
Share price
-1.55%
Change (1 day)
-54.76%
Change (1 year)
Categories
Revenue for Day One Biopharmaceuticals (DAWN)
Revenue in 2025 (TTM): C$0.22 Billion
According to Day One Biopharmaceuticals's latest financial reports the company's current revenue (TTM 
) is C$0.22 Billion. In 2024 the company made a revenue of C$0.18 Billion an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Day One Biopharmaceuticals from 2020 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | C$0.22 B | 19.13% |
| 2024 | C$0.18 B | |
| 2023 | N/A | |
| 2022 | N/A | |
| 2021 | N/A | |
| 2020 | N/A |